SETD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.778200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.308100E-02
Normal-vs-Stage2
1.361990E-02
Normal-vs-Stage3
1.492400E-02
Normal-vs-Stage4
3.220400E-01
Stage1-vs-Stage2
7.645800E-01
Stage1-vs-Stage3
2.984400E-02
Stage1-vs-Stage4
4.590600E-01
Stage2-vs-Stage3
2.593600E-02
Stage2-vs-Stage4
2.752000E-01
Stage3-vs-Stage4
2.148200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.060100E-02
Normal-vs-AfricanAmerican
9.847600E-02
Normal-vs-Asian
5.964400E-02
Caucasian-vs-AfricanAmerican
8.019600E-01
Caucasian-vs-Asian
5.928400E-01
AfricanAmerican-vs-Asian
9.098000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.313700E-02
Normal-vs-Female
1.761690E-02
Male-vs-Female
9.300000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.474400E-01
Normal-vs-Age(41-60Yrs)
1.710250E-02
Normal-vs-Age(61-80Yrs)
2.458200E-02
Normal-vs-Age(81-100Yrs)
8.455700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.616200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.947400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.756800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.060200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.250120E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.141700E-02
Normal-vs-Daily Drinker
2.227900E-02
Normal-vs-Weekly Drinker
2.159800E-02
Normal-vs-Occasional Drinker
8.053700E-02
Normal-vs-Social Drinker
1.286360E-02
Non Drinker-vs-Daily Drinker
7.909600E-01
Non Drinker-vs-Weekly Drinker
8.352800E-01
Non Drinker-vs-Occasional Drinker
2.821600E-01
Non Drinker-vs-Social Drinker
5.195400E-01
Daily Drinker-vs-Weekly Drinker
6.602000E-01
Daily Drinker-vs-Occasional Drinker
4.078000E-01
Daily Drinker-vs-Social Drinker
6.832800E-01
Weekly Drinker-vs-Occasional Drinker
2.616000E-01
Weekly Drinker-vs-Social Drinker
4.002600E-01
Occasional Drinker-vs-Social Drinker
6.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.401620E-01
Normal-vs-Grade 2
4.800600E-01
Normal-vs-Grade 3
4.989400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.445400E-01
Grade 1-vs-Grade 3
7.932600E-01
Grade 1-vs-Grade 4
1.401620E-01
Grade 2-vs-Grade 3
5.312200E-01
Grade 2-vs-Grade 4
4.800600E-01
Grade 3-vs-Grade 4
4.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.914240E-02
Normal-vs-NonDiabetic
1.910300E-02
Diabetic-vs-NonDiabetic
3.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.689500E-02
Normal-vs-NoPancreatitis
1.517840E-02
Pancreatitis-vs-NoPancreatitis
4.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.147600E-02
Normal-vs-N1
1.627720E-02
N0-vs-N1
5.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.074200E-02
Normal-vs-TP53-NonMutant
1.107760E-01
TP53-Mutant-vs-TP53-NonMutant
9.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
